0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Immunology

Buy Now

Therapeutic Targets of the TNF Superfamily (Hardcover, 2009 ed.) Loot Price: R4,374
Discovery Miles 43 740
Therapeutic Targets of the TNF Superfamily (Hardcover, 2009 ed.): Iqbal S. Grewal

Therapeutic Targets of the TNF Superfamily (Hardcover, 2009 ed.)

Iqbal S. Grewal

Series: Advances in Experimental Medicine and Biology, 647

 (sign in to rate)
Loot Price R4,374 Discovery Miles 43 740 | Repayment Terms: R410 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

Tumor necrosis factor (TNF) superfamily is a rapidly growing family of cytokines that interacts with a corresponding superfamily of receptors. Ligand-receptor interactions of this superfamily are involved in numerous biological processes ranging from hematopoiesis to pleiotropic cellular responses, including activation, proliferation, differentiation, and apoptosis. The particular response depends on the receptor the cell type, and the concurrent signals received by the cell. Worldwide interest in the TNF field surged dramatically early in 1984 with the cloning and defining of the profound cellular effects of the first member of this family, TNFa. Subsequently, the major influence of TNFa on the development and functioning of the immune system was established. Today, over 20 human TNF ligands and their more than 30 corresponding receptors have been identified. Few receptors still remain orphans. What has emerged over the years is that most TNF ligands bind to one distinct receptor and some of the TNF ligands are able to bind to multiple TNF receptors, explaining to some extent the apparent disparity in the number of TNF receptors and ligands. Yet, in spite of some redundancy in TNF ligand/receptor interactions, it is clear that in vivo spatial, temporal, and indeed cell- and tissue-specific expression of both ligands and their receptors are important factors in determining the precise nature of cellular physiological and pathological processes they control.

TNF superfamily has been the most highly investigated area of basic medical research for over two decades. These investigations have benefited from the enormous growth in our understanding of the principal functions of theimmune system and the explosion in the knowledge involved in regulation of normal and pathological immune response. In addition, much has been learned about the molecular mechanisms of programmed cell death and the escape of tumor cells from apoptotic demise and from discovery of the key role played by TNF ligands in this process. As the functioning of these superfamily members is very complex, understanding TNF ligands and their receptor biology requires a mA(c)lange of research activities in many different disciplines including organ development, molecular biology, experimental pathology, and immunology. As a consequence of intensive studies in multiple areas over many years, much has been learned. A key role of members of this superfamily in normal functioning of the immune system, autoimmunity, and other fundamental cellular process by which tumor cells develop has been established. Many novel mechanisms involving TNF superfamily members in the disease development process have been defined, and a unified concept and new perspectives have also emerged. For example, abrasions in the innate immune system, so far not considered critical in autoimmunity, have found increasing attention, and TNF-directed and not antigen directed therapy has emerged as the most impressive therapeutic advance in managing autoimmunity in humans. These findings provide a foundation for novel drug design efforts that are poised to utilize newly acquired knowledge. Several of these strategies have already materialized into successful therapeutics such as use of TNF for cancers and anti-TNFa antibodies and TNFR-Fc for autoimmune diseases, and many have advanced to human clinical trials, while many more are stillbeing tested in preclinical settings.

As in other rapidly evolving fields, these advances are not necessarily congruent and are often difficult to organize into a cogent whole. The aim of Therapeutic Targets of the TNF Superfamily is to make readily available the major research important in the exploitation of this family for developing therapeutic strategies for human diseases, in a single volume. Under the auspices of Landes Bioscience, I have undertaken the task to concisely consolidate current knowledge of key TNF superfamily members focusing on both basic aspects and their clinical application. In this volume, a number of leading scientists in the field cover many aspects of biology of TNF superfamily members, ranging from the cloning and characterization of TNF ligands and their receptors, through the use of animal models to study their functions in vivo and their exploitation for human therapeutic use. Each chapter also includes relevant background information and provides useful bibliography for a more detailed analysis, making the study of TNF ligands/receptors accessible at all levels of expertise.

General

Imprint: Springer-Verlag New York
Country of origin: United States
Series: Advances in Experimental Medicine and Biology, 647
Release date: 2009
First published: 2009
Editors: Iqbal S. Grewal
Dimensions: 254 x 178 x 18mm (L x W x T)
Format: Hardcover
Pages: 220
Edition: 2009 ed.
ISBN-13: 978-0-387-89519-2
Categories: Books > Medicine > General issues > Medical equipment & techniques > Medical research
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Immunology > General
Promotions
LSN: 0-387-89519-1
Barcode: 9780387895192

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

You might also like..

Vaxxers - The Inside Story Of The Oxford…
Sarah Gilbert, Catherine Green Paperback R118 Discovery Miles 1 180
Handbook Of HIV Medicine
Douglas Wilson, Mark Cotton, … Paperback  (1)
R704 R635 Discovery Miles 6 350
Lahita's Systemic Lupus Erythematosus
Robert G. Lahita Hardcover R5,987 Discovery Miles 59 870
Immunotherapy in Resistant Cancer: From…
Jorge Morales Montor, Mariana Segovia Hardcover R3,550 Discovery Miles 35 500
Advances in Immunology, Volume 140
Frederick Alt Hardcover R4,242 Discovery Miles 42 420
Advances in Immunology, Volume 139
Frederick Alt Hardcover R4,246 Discovery Miles 42 460
Advances in Applied Microbiology, Volume…
Geoffrey M. Gadd, Sima Sariaslani Hardcover R3,133 Discovery Miles 31 330
Advances in Immunology, Volume 137
Frederick Alt Hardcover R4,249 Discovery Miles 42 490
Advances in Immunology, Volume 133
Frederick Alt Hardcover R4,255 Discovery Miles 42 550
Aeroallergen and Food Immunotherapy, An…
Linda S. Cox, Anna H Nowak-Wegrzyn Hardcover R1,697 Discovery Miles 16 970
Colorectal Cancer, An Issue of…
Leonard B Saltz Hardcover R1,940 Discovery Miles 19 400
Computer-Aided Vaccine Design
Joo Chuan Tong, Shoba Ranganathan Hardcover R3,097 Discovery Miles 30 970

See more

Partners